Advertisement

Placenta Accreta Spectrum

Prenatal Diagnosis and Management

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Obstetrics and Gynecology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jauniaux E.
        • Bunce C.
        • Gronbeck L.
        • et al.
        Prevalence and main outcomes of placenta accreta spectrum: a systematic review and meta-analysis.
        Am J Obstet Gynecol. 2019; 221: 208-218
        • Gafvels M.E.
        • Coukos G.
        • Sayegh R.
        • et al.
        Regulated expression of the trophoblast alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Differentiation and cAMP modulate protein and mRNA levels.
        J Biol Chem. 1992; 267: 21230-21234
        • Tantbirojn P.
        • Crum C.P.
        • Parast M.M.
        Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast.
        Placenta. 2008; 29: 639-645
        • Wehrum M.J.
        • Buhimschi I.A.
        • Salafia C.
        • et al.
        Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast.
        Am J Obstet Gynecol. 2011; 204: 411 e411
        • Shellhaas C.S.
        • Gilbert S.
        • Landon M.B.
        • et al.
        The frequency and complication rates of hysterectomy accompanying cesarean delivery.
        Obstet Gynecol. 2009; 114: 224-229
        • Belfort M.A.
        • Publications Committee SfM-FM
        Placenta accreta.
        Am J Obstet Gynecol. 2010; 203: 430-439
        • Miller D.A.
        • Chollet J.A.
        • Goodwin T.M.
        Clinical risk factors for placenta previa-placenta accreta.
        Am J Obstet Gynecol. 1997; 177: 210-214
        • Hull A.D.
        • Resnik R.
        Placenta accreta and postpartum hemorrhage.
        Clin Obstet Gynecol. 2010; 53: 228-236
        • Jauniaux E.
        • Chantraine F.
        • Silver R.M.
        • et al.
        Diagnosis FPA, Management Expert Consensus P. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology.
        Int J Gynaecol Obstet. 2018; 140: 265-273
        • Silver R.M.
        • Landon M.B.
        • Rouse D.J.
        • et al.
        Maternal morbidity associated with multiple repeat cesarean deliveries.
        Obstet Gynecol. 2006; 107: 1226-1232
        • Marshall N.E.
        • Fu R.
        • Guise J.M.
        Impact of multiple cesarean deliveries on maternal morbidity: a systematic review.
        Am J Obstet Gynecol. 2011; 205: 262 e261-268
        • Pekar-Zlotin M.
        • Melcer Y.
        • Levinsohn-Tavor O.
        • et al.
        Cesarean Scar Pregnancy and Morbidly Adherent Placenta: Different or Similar?.
        Isr Med Assoc J. 2017; 19: 168-171
        • Timor-Tritsch I.E.
        • Monteagudo A.
        • Cali G.
        • et al.
        Cesarean scar pregnancy and early placenta accreta share common histology.
        Ultrasound Obstet Gynecol. 2014; 43: 383-395
        • Timor-Tritsch I.E.
        • Monteagudo A.
        • Cali G.
        • et al.
        Cesarean scar pregnancy is a precursor of morbidly adherent placenta.
        Ultrasound Obstet Gynecol. 2014; 44: 346-353
        • Buca D.
        • Liberati M.
        • Cali G.
        • et al.
        Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis.
        Ultrasound Obstet Gynecol. 2018; 52: 304-309
        • D'Antonio F.
        • Iacovella C.
        • Bhide A.
        Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis.
        Ultrasound Obstet Gynecol. 2013; 42: 509-517
        • Jauniaux E.
        • Collins S.
        • Burton G.J.
        Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging.
        Am J Obstet Gynecol. 2018; 218: 75-87
        • Bowman Z.S.
        • Eller A.G.
        • Kennedy A.M.
        • et al.
        Interobserver variability of sonography for prediction of placenta accreta.
        J Ultrasound Med. 2014; 33: 2153-2158
        • Eller A.G.
        • Bennett M.A.
        • Sharshiner M.
        • et al.
        Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care.
        Obstet Gynecol. 2011; 117: 331-337
        • Shamshirsaz A.A.
        • Fox K.A.
        • Salmanian B.
        • et al.
        Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach.
        Am J Obstet Gynecol. 2015; 212: 218 e211-219
        • Warshak C.R.
        • Ramos G.A.
        • Eskander R.
        • et al.
        Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta.
        Obstet Gynecol. 2010; 115: 65-69
        • Abinader R.R.
        • Macdisi N.
        • El Moudden I.
        • Abuhamad A.
        First-trimester ultrasound diagnostic features of placenta accreta spectrum in low-implantation pregnancies.
        Ultrasound Obstet Gynecol. 2021; https://doi.org/10.1002/uog.24828. Epub ahead of print
        • Ballas J.
        • Pretorius D.
        • Hull A.D.
        • et al.
        Identifying sonographic markers for placenta accreta in the first trimester.
        J Ultrasound Med. 2012; 31: 1835-1841
        • Comstock C.H.
        • Lee W.
        • Vettraino I.M.
        • et al.
        The early sonographic appearance of placenta accreta.
        J Ultrasound Med. 2003; 22: 19-23
        • Comstock C.H.
        • Bronsteen R.A.
        The antenatal diagnosis of placenta accreta.
        BJOG. 2014; 121: 171-181
        • Comstock C.H.
        • Love Jr., J.J.
        • Bronsteen R.A.
        • et al.
        Sonographic detection of placenta accreta in the second and third trimesters of pregnancy.
        Am J Obstet Gynecol. 2004; 190: 1135-1140
        • Wong H.S.
        • Cheung Y.K.
        • Zuccollo J.
        • et al.
        Evaluation of sonographic diagnostic criteria for placenta accreta.
        J Clin Ultrasound. 2008; 36: 551-559
        • Gielchinsky Y.
        • Mankuta D.
        • Rojansky N.
        • et al.
        Perinatal outcome of pregnancies complicated by placenta accreta.
        Obstet Gynecol. 2004; 104: 527-530
        • Hudon L.
        • Belfort M.A.
        • Broome D.R.
        Diagnosis and management of placenta percreta: a review.
        Obstet Gynecol Surv. 1998; 53: 509-517
        • Cali G.
        • Giambanco L.
        • Puccio G.
        • et al.
        Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta.
        Ultrasound Obstet Gynecol. 2013; 41: 406-412
        • Warshak C.R.
        • Eskander R.
        • Hull A.D.
        • et al.
        Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta.
        Obstet Gynecol. 2006; 108: 573-581
        • Twickler D.M.
        • Lucas M.J.
        • Balis A.B.
        • et al.
        Color flow mapping for myometrial invasion in women with a prior cesarean delivery.
        J Matern Fetal Med. 2000; 9: 330-335
        • Wong H.S.
        • Cheung Y.K.
        • Strand L.
        • et al.
        Specific sonographic features of placenta accreta: tissue interface disruption on gray-scale imaging and evidence of vessels crossing interface- disruption sites on Doppler imaging.
        Ultrasound Obstet Gynecol. 2007; 29: 239-240
        • Rac M.W.
        • Dashe J.S.
        • Wells C.E.
        • et al.
        Ultrasound predictors of placental invasion: the Placenta Accreta Index.
        Am J Obstet Gynecol. 2015; 212: 343 e341-347
        • Comstock C.H.
        Antenatal diagnosis of placenta accreta: a review.
        Ultrasound Obstet Gynecol. 2005; 26: 89-96
        • Chou M.M.
        • Ho E.S.
        • Lee Y.H.
        Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound.
        Ultrasound Obstet Gynecol. 2000; 15: 28-35
        • Shainker S.A.
        • Coleman B.
        • Timor-Tritsch I.E.
        • et al.
        Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum.
        Am J Obstet Gynecol. 2021; 224: B2-B14
        • Baughman W.C.
        • Corteville J.E.
        • Shah R.R.
        Placenta accreta: spectrum of US and MR imaging findings.
        Radiographics. 2008; 28: 1905-1916
        • Dwyer B.K.
        • Belogolovkin V.
        • Tran L.
        • et al.
        Prenatal diagnosis of placenta accreta: sonography or magnetic resonance imaging?.
        J Ultrasound Med. 2008; 27: 1275-1281
        • Einerson B.D.
        • Rodriguez C.E.
        • Kennedy A.M.
        • et al.
        Magnetic resonance imaging is often misleading when used as an adjunct to ultrasound in the management of placenta accreta spectrum disorders.
        Am J Obstet Gynecol. 2018; 218: 618 e611-618 e617
        • Maldjian C.
        • Adam R.
        • Pelosi M.
        • et al.
        MRI appearance of placenta percreta and placenta accreta.
        Magn Reson Imaging. 1999; 17: 965-971
        • Zelop C.
        • Nadel A.
        • Frigoletto Jr., F.D.
        • et al.
        Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein.
        Obstet Gynecol. 1992; 80: 693-694
        • Kupferminc M.J.
        • Tamura R.K.
        • Wigton T.R.
        • et al.
        Placenta accreta is associated with elevated maternal serum alpha-fetoprotein.
        Obstet Gynecol. 1993; 82: 266-269
        • Society of Gynecologic Oncology
        • American College of Obstetricians and Gynecologists and the Society for Maternal–Fetal Medicine
        • Cahill A.G.
        • et al.
        Placenta Accreta Spectrum.
        Am J Obstet Gynecol. 2018; 219: B2-B16
        • Silver R.M.
        • Fox K.A.
        • Barton J.R.
        • et al.
        Center of excellence for placenta accreta.
        Am J Obstet Gynecol. 2015; 212: 561-568
        • Esakoff T.F.
        • Sparks T.N.
        • Kaimal A.J.
        • et al.
        Diagnosis and morbidity of placenta accreta.
        Ultrasound Obstet Gynecol. 2011; 37: 324-327
        • Morlando M.
        • Schwickert A.
        • Stefanovic V.
        • et al.
        Maternal and neonatal outcomes in planned versus emergency cesarean delivery for placenta accreta spectrum: A multinational database study.
        Acta Obstet Gynecol Scand. 2021; 100: 41-49
        • Marcellin L.
        • Delorme P.
        • Bonnet M.P.
        • et al.
        Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
        Am J Obstet Gynecol. 2018; 219: 193 e191
        • Silver R.M.
        • Barbour K.D.
        Placenta accreta spectrum: accreta, increta, and percreta.
        Obstet Gynecol Clin North Am. 2015; 42: 381-402
      1. Committee on Obstetric P. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation.
        Obstet Gynecol. 2017; 130: e102-e109
        • Seet E.L.
        • Kay H.H.
        • Wu S.
        • et al.
        Placenta accreta: depth of invasion and neonatal outcomes.
        J Matern Fetal Neonatal Med. 2012; 25: 2042-2045
        • Lilker S.J.
        • Meyer R.A.
        • Downey K.N.
        • et al.
        Anesthetic considerations for placenta accreta.
        Int J Obstet Anesth. 2011; 20: 288-292
        • Eller A.G.
        • Porter T.F.
        • Soisson P.
        • et al.
        Optimal management strategies for placenta accreta.
        BJOG. 2009; 116: 648-654
        • Bodner L.J.
        • Nosher J.L.
        • Gribbin C.
        • et al.
        Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta.
        Cardiovasc Intervent Radiol. 2006; 29: 354-361
        • Greenberg J.I.
        • Suliman A.
        • Iranpour P.
        • et al.
        Prophylactic balloon occlusion of the internal iliac arteries to treat abnormal placentation: a cautionary case.
        Am J Obstet Gynecol. 2007; 197: 470 e471-474
        • Collins S.L.
        • Alemdar B.
        • van Beekhuizen H.J.
        • et al.
        Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta.
        Am J Obstet Gynecol. 2019; 220: 511-526
        • Ballas J.
        • Hull A.D.
        • Saenz C.
        • et al.
        Preoperative intravascular balloon catheters and surgical outcomes in pregnancies complicated by placenta accreta: a management paradox.
        Am J Obstet Gynecol. 2012; 207: 216 e211-215
        • Cali G.
        • Forlani F.
        • Giambanco L.
        • et al.
        Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta.
        Eur J Obstet Gynecol Reprod Biol. 2014; 179: 36-41
        • Shrivastava V.
        • Nageotte M.
        • Major C.
        • et al.
        Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta.
        Am J Obstet Gynecol. 2007; 197: 402 e401-405
        • D'Antonio F.
        • Iacovelli A.
        • Liberati M.
        • et al.
        Role of interventional radiology in pregnancy complicated by placenta accreta spectrum disorder: systematic review and meta-analysis.
        Ultrasound Obstet Gynecol. 2019; 53: 743-751
        • Collaborators W.T.
        Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial.
        Lancet. 2017; 389: 2105-2116
        • Simonazzi G.
        • Saccone G.
        • Berghella V.
        Evidence on the use of tranexamic acid at cesarean delivery.
        Acta Obstet Gynecol Scand. 2016; 95: 837
        • Clark S.L.
        • Phelan J.P.
        • Yeh S.Y.
        • et al.
        Hypogastric artery ligation for obstetric hemorrhage.
        Obstet Gynecol. 1985; 66: 353-356
        • Committee on Practice B.-O.
        Practice Bulletin No. 183: Postpartum Hemorrhage.
        Obstet Gynecol. 2017; 130: e168-e186
        • Bernstein H.H.
        • Rosenblatt M.A.
        • Gettes M.
        • et al.
        The ability of the Haemonetics 4 Cell Saver System to remove tissue factor from blood contaminated with amniotic fluid.
        Anesth Analg. 1997; 85: 831-833
        • Waters J.H.
        • Biscotti C.
        • Potter P.S.
        • et al.
        Amniotic fluid removal during cell salvage in the cesarean section patient.
        Anesthesiology. 2000; 92: 1531-1536
        • ACOG Practice Bulletin No. 120
        Use of prophylactic antibiotics in labor and delivery.
        Obstet Gynecol. 2011; 117: 1472-1483
        • Fox K.A.
        • Shamshirsaz A.A.
        • Carusi D.
        • et al.
        Conservative management of morbidly adherent placenta: expert review.
        Am J Obstet Gynecol. 2015; 213: 755-760
        • Palacios Jaraquemada J.M.
        • Pesaresi M.
        • Nassif J.C.
        • et al.
        Anterior placenta percreta: surgical approach, hemostasis and uterine repair.
        Acta Obstet Gynecol Scand. 2004; 83: 738-744
        • Perez-Delboy A.
        • Wright J.D.
        Surgical management of placenta accreta: to leave or remove the placenta?.
        BJOG. 2014; 121: 163-169
        • Pala S.
        • Atilgan R.
        • Baspinar M.
        • et al.
        Comparison of results of Bakri balloon tamponade and caesarean hysterectomy in management of placenta accreta and increta: a retrospective study.
        J Obstet Gynaecol. 2018; 38: 194-199
        • Sentilhes L.
        • Ambroselli C.
        • Kayem G.
        • et al.
        Maternal outcome after conservative treatment of placenta accreta.
        Obstet Gynecol. 2010; 115: 526-534
        • Agostini A.
        • Vejux N.
        • Bretelle F.
        • et al.
        Value of laparoscopic assistance for vaginal hysterectomy with prophylactic bilateral oophorectomy.
        Am J Obstet Gynecol. 2006; 194: 351-354
        • Kayem G.
        • Davy C.
        • Goffinet F.
        • et al.
        Conservative versus extirpative management in cases of placenta accreta.
        Obstet Gynecol. 2004; 104: 531-536
        • Eshkoli T.
        • Weintraub A.Y.
        • Sergienko R.
        • et al.
        Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births.
        Am J Obstet Gynecol. 2013; 208: 219 e211-217
        • Sentilhes L.
        • Kayem G.
        • Ambroselli C.
        • et al.
        Fertility and pregnancy outcomes following conservative treatment for placenta accreta.
        Hum Reprod. 2010; 25: 2803-2810
        • Kabiri D.
        • Hants Y.
        • Shanwetter N.
        • et al.
        Outcomes of subsequent pregnancies after conservative treatment for placenta accreta.
        Int J Gynaecol Obstet. 2014; 127: 206-210
        • Lee P.S.
        • Kempner S.
        • Miller M.
        • et al.
        Multidisciplinary approach to manage antenatally suspected placenta percreta: updated algorithm and patient outcomes.
        Gynecol Oncol Res Pract. 2017; 4: 11
        • Clausen C.
        • Lonn L.
        • Langhoff-Roos J.
        Management of placenta percreta: a review of published cases.
        Acta Obstet Gynecol Scand. 2014; 93: 138-143